- 2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update
Zoufang Huang et al, 2022, Frontiers in Pharmacology CrossRef - Warburg and pasteur phenotypes modulate cancer behavior and therapy
Caner Karaca et al, 2022, Anti-Cancer Drugs CrossRef - MARK2 potentiate aerobic glycolysis‐mediated cell growth in breast cancer through regulating mTOR/HIF‐1α and p53 pathways
Lavanya Ponnusamy et al, 2022, Journal of Cellular Biochemistry CrossRef - Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy
Ali F. Abdel-Wahab et al, 2019, Pharmacological Research CrossRef - Anti-Glycolytic Drugs in the Treatment of Hepatocellular Carcinoma: Systemic and Locoregional Options
Miles Pourbaghi et al, 2023, Current Oncology CrossRef - PI3K/Akt/FoxO pathway mediates glycolytic metabolism in HepG2 cells exposed to triclosan (TCS)
Jing An et al, 2020, Environment International CrossRef - Metabolic changes in tumor cells and tumor-associated macrophages: A mutual relationship
Romana T. Netea-Maier et al, 2018, Cancer Letters CrossRef - Cytosolic 5′-Nucleotidase II Silencing in a Human Lung Carcinoma Cell Line Opposes Cancer Phenotype with a Concomitant Increase in p53 Phosphorylation
Rossana Pesi et al, 2018, International Journal of Molecular Sciences CrossRef - Targeting glucose metabolism in cancer: a new class of agents for loco-regional and systemic therapy of liver cancer and beyond?
Lynn Jeanette Savic et al, 2016, Hepatic Oncology CrossRef - Autophagy inhibition potentiates energy restriction‐induced cell death in hepatocellular carcinoma cells
Sara M. Elgendy et al, 2024, IUBMB Life CrossRef - Pharmacological strategies to inhibit intra-plaque angiogenesis in atherosclerosis
Paola Perrotta et al, 2019, Vascular Pharmacology CrossRef - The Lactate and the Lactate Dehydrogenase in Inflammatory Diseases and Major Risk Factors in COVID-19 Patients
G. S. Gupta, 2022, Inflammation CrossRef - Warburg effect, hexokinase-II, and radioresistance of laryngeal carcinoma
Jiang-Tao Zhong et al, 2017, Oncotarget CrossRef - Moderate endurance training reduced hepatic tumourigenesis associated with lower lactate overload compared to high‐intensity interval training
Lu Cao et al, 2021, Clinical and Experimental Pharmacology and Physiology CrossRef - Ethanol extracts of Balanophora laxiflora Hemsl inhibit hepatocellular carcinoma with the involvement of HKII-mediated glycolysis
Dan Liu et al, 2021, Journal of Functional Foods CrossRef - Low vitamin D and high cholesterol facilitate oral carcinogenesis in 4NQO‐induced rat models via regulating glycolysis
Rasim Gumus et al, 2023, Oral Diseases CrossRef - Mitochondrial dynamics and metabolic regulation control T cell fate in the thymus
Rima Elhage et al, 2024, Frontiers in Immunology CrossRef - Novel mutation in hexokinase 2 confers resistance to 2-deoxyglucose by altering protein dynamics
Erich Hellemann et al, 2022, PLOS Computational Biology CrossRef - Glycolysis Inhibition as a Strategy for Hepatocellular Carcinoma Treatment?
A.P. Alves et al, 2018, Current Cancer Drug Targets CrossRef - Metabonomics applied in exploring the antitumour mechanism of physapubenolide on hepatocellular carcinoma cells by targeting glycolysis through the Akt-p53 pathway
Ting Ma et al, 2016, Scientific Reports CrossRef - FDP-Na-induced enhancement of glycolysis impacts larval growth and development and chitin biosynthesis in fall webworm, Hyphantria cunea (Lepidoptera: Arctiidae)
Shengyu Zhang et al, 2023, Pesticide Biochemistry and Physiology CrossRef - Pharmacological interventions part IV: Metabolic modifiers
Tomas Koltai et al, 2020, An Innovative Approach to Understanding and Treating Cancer: Targeting pH CrossRef - Carbohydrate metabolism in prostate cancer
Tomas Koltai et al, 2021, Prostate Cancer Metabolism CrossRef - Glycolytic stress deteriorates 229E virulence to improve host defense response
Neha Kaushik et al, 2023, Microbes and Infection CrossRef